Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 84 total PSOs listed by AHRQ.

Alliance for Patient Medication Safety
PSO Number: P0020
Component of Parent Org(s):
  • NASPA
Effective Date and Time of Initial Listing: December 10, 2008 12:01 AM ET
Street Address: 2530 Professional Road, Suite 202, Richmond, Virginia 23235
PSO Phone Number: (804) 422-6311
Point of Contact: Taramarie (Tara) Modisett
Point of Contact Phone: (804) 422-6311
Point of Contact Email: tara@naspa.us (link is external)
Next biennial attestation for Two Contracts due between 12/10/2018 and 12/09/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
American Medical Foundation Patient Safety Organization
PSO Number: P0141
Component of Parent Org(s):
  • American Medical Foundation for Peer Review and Education
  • The American Medical Foundation for Peer Review and Education
Effective Date and Time of Initial Listing: March 13, 2013 12:01 AM ET
Street Address: 237 S. 18th Street, 11th Floor, 11D, Philadelphia, Pennsylvania 19103
PSO Phone Number: 215-545-6363
Point of Contact: Evelyn Baram-Clothier Ph.G, JD
Point of Contact Phone: 215-545-6363
Point of Contact Email: ebc@medicalfoundation.org (link is external)
Next biennial attestation for Two Contracts due between 03/13/2019 and 03/12/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
QA to QI LLC
PSO Number: P0091
Effective Date and Time of Initial Listing: June 30, 2010 12:01 AM ET
Street Address: 111 Hunter Drive, West Hartford , Connecticut 06107-1018
PSO Phone Number: (860) 521-8484
Point of Contact: Marc T Edwards MD, MBA
Point of Contact Phone: (860) 521-8484
Point of Contact Email: Marc@QAtoQI.com (link is external)
Next biennial attestation for Two Contracts due between 06/30/2018 and 06/29/2020
Disclosures & Finding: The Department of Health and Human Services determined no action was required regarding the PSO's relationships with the following contracting provider(s):
  • St. Joseph's Hospital, Syracuse, NY
Subject to FDA-Regulated Reporting Entity Guidance: No
Society for Vascular Surgery Patient Safety Organization, LLC
PSO Number: P0106
Component of Parent Org(s):
  • Society for Vascular Surgery
Effective Date and Time of Initial Listing: February 16, 2011 12:01 AM ET
Street Address: 633 North Saint Clair Street, 22nd Floor, Chicago, Illinois 60611
PSO Phone Number: (800) 258-7188
Point of Contact: James K. Wadzinski
Point of Contact Phone: 312-334-2311
Point of Contact Email: jwadzinski@vascularsociety.org (link is external)
Next biennial attestation for Two Contracts due between 02/16/2019 and 02/15/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The Envision Healthcare Center for Quality and Patient Safety, LLC
PSO Number: P0197
Component of Parent Org(s):
  • Envision Healthcare
Effective Date and Time of Initial Listing: October 19, 2017 12:01 AM ET
Street Address: 1A Burton Hills Boulevard, Nashville, Tennessee 37215
PSO Phone Number: (615) 665-3558
Point of Contact: Debbie Cibulka
Point of Contact Phone: (615) 665-3558
Point of Contact Email: deborah.cibulka@shcr.com (link is external)
Next biennial attestation for Two Contracts due between 10/19/2017 and 10/18/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No